Engineering better drug delivery

Tom Dziubla, Gill Associate Professor in the Department of Chemical and Materials Engineering at the University of Kentucky, studies antioxidant polymers, working to answer the question, "Can we take a material and develop it from things that are antioxidant and turn it into a biocompatible material?"

Why? So we can treat a number of oxidative stress diseases, where are believed to be beneficial.

Unfortunately, as Professor Dziubla said in the video below, "There's been a lot of with antioxidants that haven't gone anywhere and it's … the antioxidant paradox. We see great effects in cells. We see good effects in animals, but we see it fail in humans; the question is why?"

Dziubla, who is also a member of the drug discovery, delivery and translational therapeutics research group at Markey Cancer Center, believes the issue lies in pharmacology; antioxidants are not reaching the areas in cells necessary and for the duration needed to produce the correct response. "Our polymers can actually overcome both of those limitations," he said.

Dziubla and his research team are taking natural antioxidants—such as from spices and green tea extract—and turning them into polymers." As the polymer degrades, it's releasing that initial component naturally or slowly over time locally to get the response out that we want," Dziubla said.

Explore further

Large doses of antioxidants may be harmful to neuronal stem cells

Citation: Engineering better drug delivery (2015, August 18) retrieved 1 April 2020 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments